Back to 
Russell Investments Group, Ltd.
Russell Investments Group, Ltd.
ALXNShowing 0 of 12 quarters
Position history for Russell Investments Group, Ltd.'s holdings in ALEXION PHARMACEUTICALS INC
As of its Q2 2021 13F, Russell Investments Group held 216,189 shares of ALXN (Alexion Pharmaceuticals), worth $39.7M. Russell Investments Group's 13F filings listed ALXN from Q4 2018 to Q2 2021, 11 quarterly filings. ALXN was 0.1% of Russell Investments Group's reported 13F portfolio.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of ALXN: FMR LLC, STATE STREET CORP